PATE-E inhibitors represent a fascinating and specialized category within the broader spectrum of chemical compounds. These inhibitors are characterized by their ability to specifically interfere with the activity of the PATE-E protein, a member of the PATE family of proteins. PATE, which stands for "Prostate And Testis Expressed," encompasses a group of proteins with varied roles in cellular processes, particularly within reproductive tissues. PATE-E, one such protein, has garnered attention due to its unique structural attributes and the specific pathways it influences within cellular environments. The inhibition of PATE-E involves intricate molecular interactions where the inhibitor molecules bind to the active sites or allosteric sites of the PATE-E protein, thereby altering its functional conformation and impeding its normal activity. These interactions are highly selective, often involving precise molecular mimicry or competitive binding, which underscores the sophistication of PATE-E inhibitors in selectively targeting this protein.
The synthesis and study of PATE-E inhibitors require advanced techniques in organic chemistry and molecular biology. Researchers employ a variety of synthetic routes to create these inhibitors, often starting with the identification of key functional groups necessary for binding efficacy. Computational modeling and high-throughput screening are frequently utilized to predict and evaluate the binding affinity and specificity of potential inhibitors. Once synthesized, these compounds undergo rigorous testing using biochemical assays to elucidate their inhibitory mechanisms and kinetic properties. Structural analyses, such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, provide detailed insights into the inhibitor-protein complexes, revealing the atomic-level interactions that govern inhibition. This intricate process not only enhances our understanding of PATE-E's biological role but also contributes to the broader knowledge of protein inhibition as a fundamental aspect of biochemistry and molecular biology.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Blocks voltage-gated sodium channels, potentially affecting cellular excitability and indirectly influencing pathways PATE-E might be involved in. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Inhibits L-type calcium channels, which could alter calcium signaling pathways potentially relevant to PATE-E's function. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Non-selective beta-adrenergic receptor antagonist, potentially affecting adrenergic signaling pathways associated with PATE-E. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, impacting the PI3K/AKT signaling pathway, which could indirectly modulate PATE-E's activity in cellular signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, affecting cell growth and proliferation pathways that PATE-E may be part of. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially altering stress response signaling pathways relevant to PATE-E's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, could affect MAPK/ERK pathways potentially linked to PATE-E's signaling processes. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Inhibits xanthine oxidase, affecting purine metabolism and potentially altering signaling pathways involving PATE-E. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Potentiates chloride ion channels, which could indirectly affect cellular signaling processes relevant to PATE-E. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR tyrosine kinase inhibitor, potentially modulating signaling pathways that PATE-E could be involved in. | ||||||